These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37845001)

  • 1. Safety update: methotrexate and photosensitivity reactions.
    Drug Ther Bull; 2023 Nov; 61(12):179. PubMed ID: 37845001
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on metformin safety in pregnancy.
    Drug Ther Bull; 2022 Jul; 60(7):99. PubMed ID: 35768138
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety update: dupilumab and ocular adverse reactions.
    Drug Ther Bull; 2023 Jan; 61(1):6. PubMed ID: 36543342
    [No Abstract]   [Full Text] [Related]  

  • 4. A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016.
    Perry LT; Bhasale A; Fabbri A; Lexchin J; Puil L; Joarder M; Mintzes B
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1054-1063. PubMed ID: 32696556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety update: withdrawal of pholcodine-containing medicines.
    Drug Ther Bull; 2023 May; 61(5):68. PubMed ID: 37041073
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety update: pregabalin during pregnancy.
    Drug Ther Bull; 2022 Aug; 60(8):117. PubMed ID: 35902098
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety update: monitoring patients taking amiodarone.
    Drug Ther Bull; 2022 Aug; 60(8):116. PubMed ID: 35772937
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate.
    Mager DR
    Home Healthc Now; 2015 Mar; 33(3):139-41. PubMed ID: 25738271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety update: prescribing metolazone.
    Drug Ther Bull; 2023 Jun; 61(6):83. PubMed ID: 36813274
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety update: hyoscine hydrobromide patches and serious anticholinergic adverse effects.
    Drug Ther Bull; 2023 Sep; 61(9):134. PubMed ID: 37536750
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety update: NSAIDs in pregnancy.
    Drug Ther Bull; 2023 Sep; 61(9):131. PubMed ID: 37438090
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical corticosteroid withdrawal reactions.
    Drug Ther Bull; 2021 Dec; 59(12):184. PubMed ID: 34824131
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety update: febuxostat and CVD.
    Drug Ther Bull; 2023 Jul; 61(7):102. PubMed ID: 37321803
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a novel regulatory pharmacovigilance prioritisation system: an evaluation of its performance at the UK Medicines and Healthcare products Regulatory Agency.
    Seabroke S; Wise L; Waller P
    Drug Saf; 2013 Oct; 36(10):1025-32. PubMed ID: 23821159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety update: metformin and vitamin B
    Drug Ther Bull; 2022 Sep; 60(9):131. PubMed ID: 35902109
    [No Abstract]   [Full Text] [Related]  

  • 16. [Direct reporting by patients of adverse drug reactions in Spain].
    Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
    Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse consequences of low-dose methotrexate medication errors: data from French poison control and pharmacovigilance centers.
    Vial T; Patat AM; Boels D; Castellan D; Villa A; Theophile H; Torrents R; Kassai B
    Joint Bone Spine; 2019 May; 86(3):351-355. PubMed ID: 30243781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New safety measures for isotretinoin.
    Drug Ther Bull; 2023 Jul; 61(7):99. PubMed ID: 37225394
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety update on home use of nebulisers for acute asthma treatment in children.
    Drug Ther Bull; 2022 Dec; 60(12):180. PubMed ID: 36261275
    [No Abstract]   [Full Text] [Related]  

  • 20. Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories.
    Boyd IW; McEwen J
    Drug Saf; 2023 Jul; 46(7):703-710. PubMed ID: 37266905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.